We developed an automated system consisting of a centrifugal analyzer and an atomic absorption spectrophotometer with Zeeman background correction to produce a profile of the concentrations of selenium and the selenium-dependent enzyme glutathione peroxidase (EC 1.11.1.9) in serum and whole blood, for use in epidemiological surveys in Northern Ireland. No pretreatment of samples other than dilution is required, and at least 35 subjects can be screened within 24 h of venesection. For selenium in serum the between-run CV was 5.7% and 4.4% within run. For selenium In whole blood the CV was 5.9% between runs, 5.7% within run. The within-run CV for glutathione peroxidase was 0.92% for serum, 1.18% for blood; the between-run CV was 8.3% for serum. To Illustrate the use of the system, we present the profile of selenium and glutathione peroxidase in serum and whole blood from 100 adults 25 to 64 years old.
are adequate for assessing Se status, at least in subjects with low Se status such as are found in New Zealand.
The purpose of the work we report here was to establish and evaluate an automated system that could be dedicated to produce a selenium and GSHPx profile from indicators currently considered adequate for estimating relative environmental exposure and satisfactory or deficient nutritional status. We have chosen to measure selenium in serum as an indicator of recent exposure and in whole blood to determine long-term exposure. We also included GSHPx as a biochemical marker for detecting decreased functional status. The system we describe allows determination of selenium and GSHPx in 200 j.L of whole blood or 100 L of serum,
and it is suitable for use in the routine clinical laboratory.
Materials and Methods

Blood Samples
All blood samples were prepared for analysis within 4 h of venesection. Whole blood collected into EDTA was sampled directly, 100 L for whole-blood selenium and 100 L for GSHPx. Both aliquots were frozen immediately at -20 #{176}C. Clotted blood was centrifuged (1500 x g, 4#{176}C, 10 mm) and the supernatant liquid was transferred to a clean plastic tube, then re-centrifuged under the same conditions to yield clear serum. We used 50 L of this for selenium and GSHPx assay, storing them at -20 #{176}C until analysis.
Selenium
Atomic absorption spectrophotometry is considered to be a suitable technique for measuring metals in large numbers of biological samples. However, pre-atomization losses, matrix interferences, and background absorption are common and major problems. The stabilized-temperature platform furnace (4) has been developed to overcome interferences in complex media. Obligatory conditions for the best performance are as follows: atomization off a L'vov platform, maximum temperature difference of approximately 1000 #{176}C between thermal pretreatment and atomization, maximum power heating for atomization (2000 #{176}C/ s), use of a matrix modifier, gas stoppage during atomization, and peak area integration.
To meet thdse conditions and carry out the analysis of selenium automatically, we used the Zeeman 3030 atomic absorption spectrophotometer fitted with a pyrolyzed graphite tube and L'vov platform, an electrodeless discharge lamp, the HGA 600 furnace, and the AS6O autosampler (all from Perkin-Elmer Ltd., Beaconsfield, Bucks., U.K.). No pretreatment of samples was required other than dilution. To offset the effect of matrix interferences, we calibrated the instrument by the classical method of premixed standard additions.
To prepare the calibration curves, we used samples of pooled serum or blood supplemented with either an equal volume of dilute nitric acid, 2 mLIL (blank), or a standard prepared in nitric acid, 2 mLIL, by dilution from a 1000 mg/L stock solution (BDH Chemicals Ltd., Poole, Dorset, U.K. Successful analysis depends on both the accuracy of the injection and the in-furnace heating of the sample. It is imperative that the irtjector place the sample correctly and that the surface tension allows the sample to flow over the whole of the upper surface of the platform. The initial step of drying the sample is crucial; sputtering must be avoided, because any material deposited on the wall of the tube will be atomized too early and so will not be recorded. The optimum conditions for each run were predetermined by trial and error. At the end of the drying stage the temperature was increased to 900 #{176}C (ramp 5 s) and held there for 60 to 70 s. With maximum power heating the temperature was then increased to 2100 #{176}C, the flow of purge gas was stopped, and readings were taken during the next 3 s. The background-corrected peak area was calculated for the last 2.5 s of atomization, and the concentration of Se present was reported on the printer.
Glutathione Peroxidase
For estimation of enzyme activity in both serum and whole blood we used the Cobas Fara centrifugal analyzer (Roche Products Ltd., Welwyn Garden City, Herts., U.K.) and a method based on the coupled assay sisted of 50 p.L of 9.8 molIL hydrogen peroxide (confirmed by titration) in 100 mL of distilled water. The reagents, which were sufficient for 80 tests, were prepared immediately before use and kept at 4#{176}C, in an ice bath.
Whole-blood samples frozen at -20 #{176}C were thawed and diluted with 2 mL of distilled water. After thorough mixing, we centrifuged the samples for 5 mm at 4#{176}C and 1500 x g to remove debris. A 200-FL sample of the clear supernatant was added to 2.0 mL of Drabkin's reagent for the estimation of hemoglobin content in the hemolysate.
An equivalent
sample was transferred to an analyzer cup, and the enzyme activity was assayed automatically by the computer-controlled instrument.
The system, recently updated by the manufacturer, is operated by the software version . With the test program we used (Table 1) , the sample, diluent, and principal reagent are pipetted simultaneously (P) into the analyzer rotor and mixed. A blank, consisting of reagent and diluent, is automatically included (Reag/Dil).
After incubation for 60 s (I) at 37 #{176}C, start reagent (H202) is added to the cuvettes (SRi). After acceleration and mixing, the absorbance (A) is read at the pre-prograinmed time intervals. All calculations are done by the computer and are based on the change in absorbance between reading 7 and 13, i.e., after 70 s of equilibration and reaction. Various checks are made on the data and, if the reaction was satisfactory, linear regression is performed on the absorbance points within the specified interval. The rate of change of absorbance for each sample, adt, is calculated in absorbance units per mm (A/mn) and corrected for the corresponding measurement in the blank, a0/t. The net ta/t is a measure of the enzyme activity. The specific activity of GSHPx in UIL of sample in the analyzer cup, e.g., in this case in the hemolysate, is then derived as follows:
The calibration factor F, which in this protocol is 4019 (Table 1) , is derived from physical coefficients, the stoichiometry of the reactions, the geometry of the cuvette, and the volume of sample introduced into the cuvette, as follows Enzyme activity in whole blood was also expressed as mt. 
Calculation
The centrifugal analyzer used for the GSHPx assays was Sample check limit, #{163}4 0.8000 found to be reliable and satisfactory. The assay itself point 1 performed as described, produced data that satisfied the 0.90) U per gram of Hb (n = 9, CV = 3.2%). Table 3 gives the results of the profile study of 100 consecutive subjects. Slightly but significantly lower concentrations of selenium (P = 0.002) and GSHPx activity (P = 0.03) were found in the serum of women. However, whole-blood selenium did not differ between the sexes (P = 0.99). The GSHPx activity expressed as U/g Hb was significantly higher in the women. Calculated from the measurements made on the hemolysate, the mean hemoglobin concentration for the women was 122 (SD 11) g/L blood and for the men it was 139 (SD ± 12) g/L. Comparison of the activity of the enzyme in U per liter of hemolysate revealed no significant difference: it was 206 (SD 31) UIL for men, 197 (SD 35) UIL for women (P = 0.15). The corresponding values for whole blood are included in Table  3 . Significant correlations were observed between the selenium concentration in micromoles per liter and enzyme activities expressed as U per liter in both serum and whole blood. Figure 1 shows the scatter plots of individual values for selenium concentration vs GSHPx activity for both serum and whole blood, together with the correlation coefficients and P values.
Discussion
Historically, determination of selenium in biological matrices is difficult and tedious. The concentrations present are usually below those that can be determined with simple flame atomic absorption instruments, making it necessary to extract the metal and thus concentrate it. The selenium is then estimated after hydride generation or by the diaminonaphthalene fluorometric method of Watkinson (6) . The advantages of Zeeman background correction used in conjunction with the stabilized-temperature platform furnace for determination of selenium have been reviewed and evaluated (4) . In the opinion of these authors the use of Zeeman background correction frees the selenium determination from several interferences such as that from iron and phosphorus, both of which are commonly associated with the metal. They stressed that good-quality pyrolytic graphite tubes, platform atomization, and integrated absorbance readings should be used, and that the use of a matrix modifier is essential to moderate losses during charring. The reproducibility of the assays, as shown here by the between-run CVs of 5.7% and 5.9%, is acceptable and is similar to that of 5% quoted by the New Zealand group for the fluorometric method for a blood sample with a mean Se concentration of 0.050 ± 0.0024 p.gJmL (7).
Although no sample preparation other than centrifugation is involved here, the time taken to perform a run of 35 samples of either serum or blood with the program de- Fig. 1 . Relation between selenium concentration and glutathione peroxidase activity for some residents of Northern Ireland, in serum (A), and in whole blood ( Thecorrelationcoefficientsfor52 women were 0.58 (P <0.001) forserum and 0.47 (P <0.001) forwholeblood. Both correlation coefficients were0.36 for48 men(P= 0.01) scribed is about 3 h. It is thus convenient to proffle 35 subjects per day.
The literature contains many and varied modifications of the assay for GSHPx originally described by Paglia and Valentine (5), and it is generally recognized that each laboratory will have its own assay and range of values. Recently two procedures for GSHPX activity in blood were compared to assess their equivalence (8). The conclusion was that the results, although different numerically, were highly correlated and indicated a correlation of enzyme activity with Se in blood from people with low selenium status but not for those with higher Se status. The fact remains there is no standard assay for GSHPX. Moreover, an interlaboratory control scheme would be difficult to operate, because of the instability of the enzyme activity in whole blood. However, from our experience with the method described for human serum, it should be possible for laboratories with access to modern computer-driven analyzers to exchange samples of serum for comparative purposes. It might even be possible to use a pool of serum with an agreed assigned value as a calibrator.
The search for a specific universal marker of selenium status that is applicable to subjects of high, medium, or low Se status is ongoing (9). An elegant immunological study has recently shown that the GSHPx in plasma is a unique selenoglycoprotein (10). Antibodies raised against purified enzyme were specific and capable of precipitating >90% of the GSHPx activity from normal plasma. The antibodies did not precipitate erythrocyte GSHPx, thus confirming that the plasma enzyme and the erythrocyte enzyme are two different proteins and that the enzyme in plasma is not present as a by-product of cell breakage. Moreover, GSHPX protein as well as activity was deficient in the absence of selenium, indicating that inactive enzyme is not synthesized in periods of selenium deficiency. These authors (10) also determined the amount of selenium attributable to GSHPx and found that this was only 15% for erythrocyte GSHPx. Consequently, they believed that GSHPX activity could not serve as an index of Se status in healthy individuals. However, the validity of GSHPX as a reference for selenium status in residents of the areas of New Zealand with low soil selenium has been repeatedly demonstrated (1, 8, 11, 12) .
Although the erythrocyte and serum form of GSHPx differ structurally and functionally and, ideally, the two compartments should be analyzed separately, we think that there are distinct practical advantages in the use of whole blood in large epidemiological surveys. For instance, our subjects are screened from approximately 0900 to 2100 hours in health centers scattered across the country and, because of a time restriction of 4 h between venesection and the initial processing of the samples for biochemical analysis, we are often obliged to carry out this task on site. To prepare erythrocytes for analysis is time consuming, whereas whole blood can be simply aliquoted immediately, transported in an insulated container back to the laboratory, and stored frozen until the next day. Moreover, the contribution of serum enzyme activity to the total activity found in whole blood is very small. For example, from Table  3 , if it is assumed that a hemoglobin concentration of 139 g/L approximates to a hematocrit of 0.41, the contribution of serum GSHPx to whole blood GSHPX, in the case of the male group, will be approximately 146 UIL, leaving about 4180 U/L as the value for the activity arising from the erythrocytes, about 10 000 U of GSHPx activity in 1 L of erythrocytes.
This calculation ignores any contribution from the leukocytes.
Evidence from chico-pathological and epidemiological studies has suggested that a poor selenium nutriture may be etiologically important in cardiovascular disease (13-15). Northern Ireland remains at the top of the world mortality league for coronary heart disease, and seleniumdeficiency-related diseases exist in the livestock, so the selenium status of the population is of interest. In our small group of 100 subjects, in contrast to some other studies (7, (16) (17) (18) , there was a slight sex-related effect on serum selenium. The mean values were higher than those reported for New Zealand residents, which range from 0.60 to 0.80 .tmol/L (3), and the values of 0.66 (13) (25) (26) (27) .
In general, studies of normal, healthy subjects with what is assumed to be an adequate intake of selenium have failed to find a positive correlation between the metal and the enzyme in blood or plasma (8, 17, 28) . The finding of significant correlations in this small pilot study supports the hypothesis that residents of Northern
Ireland have a selenium status that is not saturated. However, these results for only 100 subjects should be interpreted with caution. Ongoing measurements for some 5000 subjects enrolled in our current surveys will provide more reliable data.
The weakness of many epidemiological surveys that have sought to establish a link between selenium status and disease (14, 16, 19,23,24) is attributable to the delay of several years between sampling and analysis and the consequent restriction to measurements of serum selenium. We have demonstrated that the side-by-side amalgamation of the Zeeman atomic absorption spectrophotometer with a centrifugal analyzer provides a powerful system for the study of selenium status in large numbers of subjects. A profile of four variables-namely, the selenium concentration and the activity of the selenium-dependent enzyme GSHPx in both serum and whole blood-can be established within a few hours of venesection.
